| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |